section name header

Symptoms

Tearing, irritation, pain, mild-to-severe photophobia. History of similar episodes or chalazia. Corneal phlyctenules are more symptomatic than conjunctival phlyctenules.

Signs

Critical

Other

Conjunctival injection, blepharitis, corneal scarring.

Differential Diagnosis

Etiology

Delayed hypersensitivity reaction usually as a result of one of the following:

Workup

  1. History: TB or recent infection? Blepharitis? Chalazia?

  2. Slit-lamp examination: Inspect the eyelid margin for signs of Staphylococcal anterior blepharitis and rosacea.

  3. PPD and/or IGRA in patients without blepharitis and those at high risk for TB.

  4. Chest radiograph or chest CT if high suspicion for TB or positive PPD or IGRA.

Treatment

Indicated for symptomatic patients.

  1. Topical steroid (e.g., loteprednol 0.5% or prednisolone acetate 1% q.i.d., depending on the severity of symptoms). A combination antibiotic/steroid can also be used q.i.d. (e.g., loteprednol 0.5%/tobramycin 0.3% or dexamethasone 0.1%/tobramycin 0.3%).

  2. Topical ophthalmic antibiotic regimen in the presence of corneal ulcer. See 4.12, Bacterial Keratitis. Otherwise, antibiotic ointment (e.g., erythromycin, bacitracin) q.h.s.

  3. Eyelid hygiene b.i.d. to t.i.d. for blepharitis. See 5.8, Blepharitis/Meibomitis.

  4. Preservative-free artificial tears four to six times per day.

  5. In severe cases of blepharitis or acne rosacea, consider doxycycline 50 to 100 mg p.o. daily to b.i.d., or erythromycin 200 mg p.o. daily to b.i.d. See 5.8, Blepharitis/Meibomitis.

  6. If the PPD, IGRA, or chest radiograph is positive for TB, refer the patient to an internist or infectious disease specialist for management.

Follow-Up

Recheck in several days to a week. Healing usually occurs over a 10- to 14-day period, with a residual stromal scar. When the symptoms have significantly improved, slowly taper the steroid. Maintain the antibiotic ointment and eyelid hygiene indefinitely. Continue oral antibiotics for 3 to 6 months at a lower daily dose (e.g., doxycycline 50 mg p.o. daily). Topical cyclosporine may be a beneficial steroid-sparing agent in patients with recurrent inflammation.